“`html
Understanding Drug Recalls with Dr. Ileana Elder
|
Drug Regulatory Process; Drug Safety |
No |
0 |
Resource Guide for Teaching Faculty
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim
|
Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs |
No |
0 |
FDA D.I.S.C.O. Burst Edition: FDA approval of Retevmo
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Accidental Exposures to Fentanyl Patches Continue to Be Deadly to Children
|
Drug Regulatory Process; Drug Safety; Opioids |
No |
0 |
Should You Give Kids Medicine for Coughs and Colds?
|
Drug Regulatory Process; Drug Safety; OTC Drug Regulations |
No |
0 |
What Does FDA Approve? Part 2
|
Drug Safety; MedWatch |
No |
0 |
Is It Really ‘FDA Approved’?
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
10 Facts about What FDA Does and Does Not Approve
|
CBD; Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Sunscreen: How to Help Protect Your Skin from the Sun
|
Sunscreen |
No |
0 |
Facts about Sunscreen
|
Sunscreen |
No |
0 |
Medicamentos
|
Drug Development; Drug Regulatory Process; Drug Safety; Español |
No |
0 |
Datos acerca de los medicamentos genéricos
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español |
No |
0 |
Hechos Sobre Los Medicamentos Genericos
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español |
No |
0 |
Medicamentos Genéricos: Preguntas y Respuestas
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español |
No |
0 |
2024 PDA/ FDA Joint Regulatory Conference
|
Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Complex Innovative Trial Design Meeting Program
|
Case Study; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Ojemda (tovorafenib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Conversations on Cancer—Strength in Numbers: Increasing Cancer Awareness While Decreasing Disparities
|
Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Minority Health |
No |
0 |
Conversations on Cancer: ODAC Chronicles – the Past, Present, and Future of Oncology Advisory Committees
|
Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Considerations for Drug Products that Contain Nanomaterials
|
Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more
|
Biosimilars; Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Minority Health, Opioids |
No |
0 |
The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad
|
Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence |
Yes |
0.5 |
Practitioners’ Guide for Improving Oral Anticoagulant Use
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
14th Annual Sentinel Initiative Public Workshop
|
COVID-19; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
6 Tip-Offs to Rip-Offs: Don’t Fall for Health Fraud Scams
|
Drug Safety; Health Fraud |
No |
0 |
|
Accelerating Access to Critical Therapies for ALS
|
Drug Development; Drug Regulatory Process |
No |
0 |
Accelerating Rare disease Cures (ARC) Program
|
Drug Development; Drug Regulatory Process; Rare Diseases |
No |
0 |
Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories
|
Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Advancing Generic Drug Development: Translating Science to Approval 2023
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
Advancing Regulatory Science at FDA
|
Drug Development; Drug Regulatory Process |
No |
0 |
Advancing Transparency and Regulatory Science Activities on the Risk Evaluation and Mitigation Strategy (REMS)
|
Drug Regulatory Process; Drug Development; Drug Safety |
Yes |
1 |
Adverse Events Associated with Compounded Drugs from Outsourcing Facilities
|
Case Study; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
No |
0 |
Airflow
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
Yes |
4 |
Application of Artificial Intelligence and Machine Learning for Precision Medicine
|
Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence |
No |
0 |
Are you on a biologic medication? What you need to know about biosimilar treatment options
|
Biosimilars |
No |
0 |
Areas of Customer Need for Outsourcing Facility Products
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Aseptic Process Simulations (Media Fills)
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
Yes |
2 |
Bench to Bedside: Integrating Sex and Gender to Improve Human Health
|
Drug Development; Drug Regulatory Process; Drug Safety; Women’s Health |
Yes |
1 |
BeSafeRx: Your Source for Online Pharmacy Information
|
Drug Safety: Health Fraud |
No |
0 |
Biological Products, Biosimilars Products, and Interchangeable Biosimilar Products
|
Biosimilars; Drug Regulatory Process; Drug Development |
No |
0 |
Biosimilar and Interchangeable Biologics: More Treatment Choices
|
Biosimilars |
No |
0 |
Biosimilar and Interchangeable Biosimilars: Review of Scientific Concepts, Case Studies, and Resources
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
Yes |
1 |
Biosimilar Basics
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
Biosimilar Basics for Patients
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
Biosimilar Manufacturing and Variation
|
Biosimilars; Drug Regulatory Process; Drug Development |
No |
0 |
Biosimilar Medications – What Health Care Providers Need to Know
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
|
Biosimilar Medications – What Patients Need to Know
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Biosimilar Regulatory Approval Pathway
|
Biosimilars; Drug Regulatory Process; Drug Development |
No |
0 |
Biosimilars: Lo que los pacientes con diabetes deben saber
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español |
No |
0 |
Biosimilars: Lo que los pacientes deben saber
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español |
No |
0 |
Biosimilars 101: A Primer for Your Practice
|
Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Yes |
0.25 |
Biosimilars 102: Interchangeability, Extrapolation, and Immunogenicity – A Regulatory Process Primer (medscape.org)
|
Biosimilars; Drug Regulatory Process; Drug Development |
Yes |
0.25 |
Biosimilars Basics Infographic
|
Biosimilars; Generic Drugs |
No |
0 |
Biosimilars Curriculum Materials for Health Care Degree Programs
|
Biosimilars; Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care
|
Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch |
Yes |
0.5 |
Biosimilars Level 1: Foundational Concepts
|
Biosimilars; Case Study Drug Regulatory Process; Drug Development |
No |
0 |
Biosimilars Level 2: Regulatory and Scientific Concepts
|
Case Study |
No |
0 |
Biosimilars Multimedia Education Materials
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Biosimilars Overview for Health Care Professionals
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Biosimilars Patient Materials
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Biosimilars Resources
|
Biosimilars; Case Study; Drug Regulatory Process; Drug Development |
No |
0 |
Biosimilars Videos
|
Drug Development; Biosimilars; Drug Regulatory Process |
No |
0 |
Biosimilars: A Review of Scientific, Regulatory, and Clinical Considerations for Health Care Providers
|
Biosimilars; Drug Regulatory Process; Drug Development |
Yes |
1 |
Biosimilars: Are they the same quality?
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Biosimilars: What Patients Need to Know
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
Biosimilars: What Patients With Diabetes Need To Know
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
Biosimilars Health Care Provider Materials
|
Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety |
No |
0 |
Bridging Efficacy and Safety to the Obese
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; MedWatch; Women’s Health |
No |
0 |
Bringing Clinical Research to Patients
|
Drug Regulatory Process; Drug Development; Drug Safety |
Yes |
1 |
Cannabis and Cannabis-Derived Products – For Healthcare Practitioners
|
Drug Regulatory Process; Drug Development; Drug Safety; Cannabidiol |
Yes |
1 |
CDER Conversation: Improving Medication Adherence and Patient Experience by Researching Patient Perceptions of Generic Drug
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
No |
0 |
CDER Webinars
|
Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND/Expanded Access; Cancer Drugs |
No |
0 |
CDER’s Emerging Drug Safety Technology Meeting Program
|
Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence |
No |
0 |
Cleanroom In-person Course
|
Compounding; Drug Regulatory Process; Drug Development |
Yes |
13.75 |
Clinical Trial Basics
|
Drug Regulatory Process; Drug Development; Drug Safety; IND/Expanded Access; Women’s Health |
No |
0 |
Clinical Trial Basics with Dr. Robert Temple
|
Drug Regulatory Process; Drug Development; Drug Safety; IND/Expanded Access; Women’s Health |
Yes |
0.5 |
Compounding Outsourcing Facilities Annual Study
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Compounding Quality Center of Excellence Annual Conference 2023
|
Compounding, COVID-19, Drug Development, Drug Regulatory Process, Drug Safety |
No |
0 |
Compounding Quality Center of Excellence Virtual Conference
|
Compounding; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Conceptos ba¡sicos sobre los biosimilares
|
Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español |
No |
0 |
|
Conversation on Paxlovid with Dr. John Farley
|
COVID-19; Drug Regulatory Process; Drug Development; Drug Safety |
Yes |
0.5 |
Conversations on Cancer, Black History Month Program: Real Talk: Our Stories as Black Oncologists at the FDA
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety, Minority Health |
No |
0 |
|
Conversations on Cancer: “What’s on the Horizon: Future of Cancer Care”
|
Cancer Drugs |
No |
0 |
|
Conversations on Cancer: Bringing Innovation to People Facing Cancer
|
Cancer Drugs |
No |
0 |
|
Conversations on Cancer: Cancer Disparities in Appalachia
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
|
Conversations on Cancer: Cancer Misinformation: Truth or Consequences
|
Cancer Drugs, Drug Development, Drug Regulatory Process, Drug Safety |
No |
0 |
|
Conversations on Cancer: How Biotech Built a Blockbuster Cancer Drug
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
|
Conversations on Cancer: Living with Metastatic Breast Cancer
|
Cancer Drugs |
No |
0 |
|
Conversations on Cancer: National Black Family Cancer Awareness Week, Engaging the Generations
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety, Minority Health |
No |
0 |
|
Conversations on Cancer: Seasons of Change: Oncology Careers
|
Cancer Drugs |
No |
0 |
|
Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
Counseling Patients on Generic Drugs
|
Generic Drugs; Drug Regulatory Process; Drug Development; Drug Safety |
Yes |
1 |
|
CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito
|
Case Study; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
Yes |
0.5 |
Development and U.S. Regulation of Preventative Vaccines
|
Drug Regulatory Process; Drug Development |
Yes |
1 |
Drug Approval Case Studies
|
Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access |
No |
0 |
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O)
|
Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
No |
0 |
Drug Shortages with CDR Emily Thakur
|
COVID-19; Drug Development; Drug Regulatory Process; Drug Safety |
Yes |
0.5 |
Drug Shortages: Root Causes and Potential Solutions
|
Drug Regulatory Process; Drug Development |
Yes |
1 |
|
Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Yes |
1 |
Enhanced Drug Distribution Security: 2023 and Beyond
|
Drug Regulatory Process; Drug Safety |
Yes |
1 |
|
Environmental Monitoring In-person Course
|
Compounding; Drug Regulatory Process; Drug Development |
Yes |
15.25 |
|
Equity of Voices video series
|
Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
No |
0 |
|
Expanded Access with Dr. Jacqueline Corrigan-Curay
|
Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access |
Yes |
0.5 |
|
FDA 101: An Overview of FDA’s Regulatory Review and Research Activities
|
Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; OTC Drug Regulations; Women’s Health |
No |
0 |
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
|
Disease States; Drug Development; Drug Regulatory Process |
Yes |
0.5 |
FDA approval of Augtyro (repotrectinib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Epkinly (epcoritamab-bysp)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Fruzaqla (fruquintinib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Jemperli (dostarlimab-gxly)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Keytruda (pembrolizumab)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Lynparza (Olaparib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of OGSIVEO (nirogacestat)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Omisirge (omidubicel-onlv)
|
Cancer Drugs, Drug Development, Drug Regulatory Process, Drug Safety |
No |
0 |
FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Polivy (polatuzumab vedotin-piiq)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Tibsovo (ivosidenib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approval of Trodelvy (sacituzumab govitecan-hziy)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women’s Health |
No |
0 |
FDA approval of Verzenio (abemaciclib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women’s Health |
No |
0 |
FDA approval of Zynyz (retifanlimab-dlwr)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women’s Health |
No |
0 |
FDA approvals of Talvey and Elrexfio
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA approvals of Tukysa (tucatinib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA D.I.S.C.O. Burst Edition: Retevmo (selpercatinib)
|
Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety |
No |
0 |
FDA Drug Info Rounds
|
Drug Safety; MedWatch; IND/Expanded Access; Drug Development; Drug Regulatory Process; Generic Drugs |
No |
0 |
FDA Drug Information Resources and Applicability to Health Care Professionals
|
